NCT/Study#
NCT03400332 /
CA027-002
A Phase 1/2a Study Of BMS-986253 In Combination With Nivolumab In Advanced Cancers
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
